Agilus 120 mg, Pulver zur Herstellung einer Injektionslösung

7680690830014 CH-69083 Pulver
Agilus 120 mg, Pulver zur Herstellung einer Injektionslösung
Agilus 120 mg, Pulver zur Herstellung einer Injektionslösung
Agilus 120 mg, Pulver zur Herstellung einer Injektionslösung
1 / 3
google

Article details

Package size
6
Selling units
6
Measure
Durchstechflasche(n)
Galenic form
Pulver
Galenic group
Lösbar zur Einnahme

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
25/10/2024
Summary of Product Characteristics
Français
25/10/2024
Summary of Product Characteristics
Italien
25/10/2024

Detailed composition

Substance Quantity Type Category
dantrolenum natricum hemiheptahydricum
120.0 MG Substance Wirkstoff (Principe actif)
hydroxypropylbetadexum
3530.0 MG Substance HBESI
macrogolum 3350
- Substance HNIDK
natrium
6.9 MG Substance HBESI

Authorization holder

Norgine AG

6005 Luzern

Authorization information

Swissmedic authorization number
69083
Drug name
Agilus, Pulver zur Herstellung einer Injektionslösung
Galenic form
PULVL
ATC Code
M03CA01
Authorization status
Z
Dispensing category
B
First authorization
27/06/2024
Authorization expiration date
26/06/2029
IT Number
01.12.0.
Domain
Human medicine
Field of application
Maligne Hyperthermie

Package details

Description (FR)
AGILUS subst sèche 120 mg flac 6 pce
Description (DE)
AGILUS Trockensub 120 mg Durchstf 6 Stk
Market launch
27/06/2024
Narcotic (BTM)
No
Buy us a coffee Explore the data